However, it's always wise to check with your doctor
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read IGF-1 LR3 Peptide: Benefits, Uses, Side Effects, Dosage, and Research
As a general clinical principle: Retest HbA1c no sooner than three months after commencing B12 replacement therapy, and ideally once haematological recovery has been confirmed Confirm haematological recovery normalisation of MCV and haemoglobin before interpreting the repeat HbA1c as reliable Use interim glucose monitoring such as fasting plasma glucose, OGTT, or self-monitored blood glucose (SMBG) to assess glycaemic control during the treatment period
I usually explain that results are gradual, reversible, and depend on the route, skin type, pigmentation pattern, lifestyle, and consistency
Potential in ED: The technique saturates the blood with oxygen, potentially aiding tissue repair and inflammation reduction